Biolase Gets $35M In Private Placement

Irvine-based dental laser manufacturer Biolase reported Tuesday that it has raised $35M in a private placement. The publicly held company said the investment came from Jack W. Schuler, Oracle Partners, L.P. and other Oracle funds, three funds managed by Camber Capital Management, LLC, Eagle Growth Partners I and II, Birchview Capital L.P., Trellus Partners, as well as its directors, officers, and employees. The company said it would use the funds to fuel its growth and innovation efforts. Biolase trades on the NASDAQ as BIOL.